AVAI BIO, INC. (AVAI)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 22, 2026

Verified against EDGAR
Total Assets
$791,750
Stockholders' Equity
-$3.2M
Cash & Equivalents
$83,586
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, AVAI BIO, INC. reported net income of -$552,041 and total assets of $791,750. Every figure below is taken directly from AVAI BIO, INC.'s SEC filings: each links to the source document on EDGAR.

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2026—-$1.7M
FY2025—-$1.1M
FY2024—-$2.1M
FY2023$276,324-$348,933
FY2022—-$126,521
FY2021—-$248,022
FY2020—-$69,593
FY2019—-$78,225

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
10-QAug 13, 2026on EDGAR ↗
10-KJul 14, 2026on EDGAR ↗
NT 10-KJun 30, 2026on EDGAR ↗
8-KMay 8, 2026on EDGAR ↗
10-QFeb 12, 2026on EDGAR ↗
8-KFeb 9, 2026on EDGAR ↗
10-QNov 14, 2025on EDGAR ↗
8-KNov 4, 2025on EDGAR ↗
8-KSep 18, 2025on EDGAR ↗
8-KSep 17, 2025on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$791,750source ↗
Stockholders’ Equity-$3.2Msource ↗
Cash & Equivalents$83,586source ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue—source ↗
Net Income-$552,041source ↗
Operating Income-$552,041source ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense—source ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)—source ↗
EPS (basic)$0.00source ↗
Shares Outstanding153.9Msource ↗
Cash from Operations-$414,258source ↗
Cash from Financing$533,299source ↗
Cash from Investing-$58,600source ↗

Restatement history

Point-in-time

20 of 188 annual fact-keys were materially restated between filings: what AVAI BIO, INC. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches AVAI’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/AVAI

MCP tool: get_sec_fundamentals ticker=AVAI

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/AVAI/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=AVAI as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/AVAI/history

MCP tool: get_fundamentals_history ticker=AVAI

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/AVAI

MCP tool: get_financial_health ticker=AVAI

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.